Form EFFECT Evoke Pharma Inc
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 |
| Accession Number: | 0001193125-25-322647 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BNB News: Binance AI’s Trading Push Meets Remittix’s PayFi Ecosystem With RTX’s November Launch Ahead
- Historic $250 Million Gift from John Paulson to Hebrew University Will Advance Engineering, Medicine, and Trauma Recovery
- Best Crypto to Buy in 2026: BONK, FLOKI or Remittix as Meme Coins Pull Back and PayFi Testing Advances?
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share